Until now, it has been up to the dermatologist’s in-depth examination of the body to detect early signs of skin cancer. However, a powerful new imaging device may soon help thousands of dermatologists identify skin cancer in its early stages so that they can effectively treat melanoma in its very early stages.
According to a recent press release, Melanoscan is the first full-body digital imaging device that can assist dermatologists with the early identification of deadly melanomas.
This digital scanning system uses an innovative time-lapse imaging technology to detect melanoma up to two years before its appearance. The study accurately assessed the risk of melanoma in over 6,000 subjects, and was able to predict who would develop melanoma in as little as five minutes. The Melanoscan device detected 27 cases of melanoma, bringing the cure rate of this deadly skin cancer to 99.3%.
Melanoma is the deadliest type of skin cancer in the United States, and according to the American Academy of Dermatology, one person in the U.S. dies from melanoma every 68 minutes. Still, this type of cancer is treatable with early detection. Men and women of all ages are encouraged to visit a dermatologist at least once every season to make sure their skin is in good health.
The Melanoscan procedure can be performed under 10 minutes, and there is no preparation required. The device uses an automated image capture system so the patient can have their pictures taken in a private room.
According to Dr. Rhett Drudge, inventor of the Melanoscan and lead researcher of the study, “the logistics of saving 7,500 lives every year in the United States through early melanoma detection are clearly daunting. However, the Melanoscan technology can be mobilized and delivered to facilitate early detection, even to the most rural communities. The greatest appeal of this technology lies in its potential to deliver a standardized melanoma screening procedure throughout the United States and beyond.”